CircuitDigest presents the Smart Home & Wearables Project Contest 2025! Win exciting prizes worth up to ₹7,00,000 and receive free development boards through our partnership with DigiKey. For ...

Two 4-inch square HDMI touchscreen displays from VIEWE and Waveshare for Raspberry Pi SBCs, Jetson Nano SBC, and computers.

Experts at the Table: Semiconductor Engineering sat down to discuss initial forays into 3D-ICs and what problems early adopters will encounter, with John Ferguson, senior director of product ...

Have you ever imagined building a drone so small it could rest comfortably in the palm of your hand, yet powerful enough to soar through the air with precision, all controlled from your smartphone?

After making a pair of game-winning field goals at the frosh/soph level a year ago, Billy Harding got his chance on the big stage Friday night. The result was the same. The sophomore left-footer ...

After making a pair of game-winning field goals at the frosh/soph level a year ago, Billy Harding got his chance on the big stage Friday night. The result was the same. The sophomore left-footer ...

With markets racing ahead again despite heightened uncertainty, passive funds have made plenty of ‘easy’ money this year. This is an intimidating backdrop for those seeking to beat the market, be it ...

There’s still plenty of income available for UK investors who want to accrue it: a FTSE 100 tracker comes with a yield of around 3.5 per cent, a 10-year UK government bond pays around 4.7 per cent and ...

To break through the technical, mass production, and yield challenges in advanced packaging processes such as 3D IC and CoWoS, SEMI, together with TSMC and ASE Holdings, has established the "3DIC ...

With "nepo babies" having a negative connotation these days, IC Mendoza's proud declaration that he is in fact one is a rather refreshing take. On social media, IC cited his showbiz heritage beginning ...

Pegcetacoplan is the first FDA-approved treatment for C3G and primary IC-MPGN, targeting excessive C3 complement activation. The phase 3 VALIANT trial showed a 68% reduction in UPCR and stabilization ...